IGCS 2020 Annual Global Meeting – Abstract

IGCS 2020 Annual Global Meeting – Abstract Phase 1 Dose-Escalation Study of STRO-002, an anti-Folate Receptor alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum Resistant/Refractory Epithelial Ovarian Cancer (OC). Dr. Naumann is...

Bristol Myers Squibb Investor Series

Bristol Myers Squibb Investor Series Bristol Myers Squibb Investor Series - Hematology June 25, 2020 at 11:30am ET WEBCAST View This Presentation   Bristol Myers Squibb Investor Series - Early Pipeline and Immuno-Oncology June 22, 2020 at 11:30am ET WEBCAST View...